Delivery Order SPE2DB22D2206-SPE2DB24FFX71
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for ABRAXANE 100 MG VIALS. The $14,980.02 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which runs through November 2026. This IDC allows the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies, including...
- This federal contract award, valued at $43,667.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of ABRAXANE 100 MG VIALS, with an ultimate completion date of November 7, 2024. The contract has a Firm Fixed Price pricing type and is not designated with a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $23,240.98 firm fixed price delivery order is for the supply of ABRAXANE 100 MG VIALS, a specialty pharmaceutical product. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,382.22, is for the delivery of ABRAXANE 100 MG VIALS, a specialty cancer medication. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a...
- This contract award is for the delivery of ABRAXANE 100 MG VIALS to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, with a ceiling value of $65,778.16. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award (SPE2DB22D3016|SPE2DB24FAQG5) was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4564002820 ABRAXANE 100 MG VIALS. The contract is a firm fixed price delivery order with a ceiling value of $2,246.82 and a performance period through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award and has also received a separate...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $9,199.46 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide ABRAXANE 100 MG vials. The contract has a completion date of February 21, 2024. Amerisourcebergen Drug Corp holds several other indefinite delivery contracts with DLA and the Department of Justice Federal Bureau of Investigation Headquarters Division to supply pharmaceuticals and medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the supply of ABRAXANE 100 MG VIALS, a pharmaceutical product, with a ceiling value of $4,833.48 and a completion date of April 30, 2024. AmerisourceBergen Drug Corporation is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...
- This federal contract award, valued at $3,786.54, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of a pharmaceutical product, specifically "ABRYSVO VIAL WITH DILUENTS". The single-award Indefinite Delivery Contract (IDC) is valued at up to $999,999,999.00 and runs through December 31, 2025. This contract serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty,...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFX71Delivery Order
This federal contract award is for the delivery of ABRAXANE 100 MG VIALS to the Defense Logistics Agency (DLA). The $10,010.18 fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is a delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a period of performance through March 6, 2024 and does not include any set-aside designation, indicating open competition. Amerisourcebergen has also secured a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 3/5/24 |